Jessica Tassan
Stock Analyst at Piper Sandler
(1.14)
# 3,780
Out of 5,090 analysts
78
Total ratings
31.82%
Success rate
-11.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $16.77 | +49.08% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $50.04 | +41.89% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $330.91 | +26.02% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $20.29 | +67.57% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $3.94 | +356.85% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.60 | +53.85% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $33.95 | +153.31% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $45.93 | +50.23% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $257.85 | +5.49% | 4 | Jul 31, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $4.01 | +99.50% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $265.44 | +40.90% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $75.63 | -2.16% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.55 | +7.42% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.59 | +58.10% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $40.50 | +72.86% | 4 | Aug 2, 2023 |
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $16.77
Upside: +49.08%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $50.04
Upside: +41.89%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $330.91
Upside: +26.02%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $20.29
Upside: +67.57%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $3.94
Upside: +356.85%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.60
Upside: +53.85%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $33.95
Upside: +153.31%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $45.93
Upside: +50.23%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $257.85
Upside: +5.49%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.01
Upside: +99.50%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $265.44
Upside: +40.90%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $75.63
Upside: -2.16%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $19.55
Upside: +7.42%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.59
Upside: +58.10%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $40.50
Upside: +72.86%